Xiangpeng Li
机构:Florida State University, University of Central Florida, Qingdao University, North China University of Science and Technology, Harbin Medical University, University of California, San Francisco, Soochow University, Affiliated Hospital of Qingdao University, National Center for Nanoscience and Technology, Central Botanical Garden · ORCID:0000-0002-4230-5676
发表论文 95 篇 · 总被引 1479 次 · h-index 21
代表论文
- In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy (2024 · Nature Communications · 被引 95)
- Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder Cancer (2024 · ACS Nano · 被引 28)
- Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer (2024 · National Science Review · 被引 26)
- In vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasis (2024 · 中国科学通报:英文版 · 被引 23)
- The regulating role of galectin-9 in immune cell populations (2024 · Frontiers in Pharmacology · 被引 15)
- Stimuli-Responsive Nanomaterials for Tumor Immunotherapy (2024 · ACS Biomaterials Science & Engineering · 被引 15)